Company: GANX
Filing Date: 2025-07-17
Form Type: 8-K
Source: 0001104659-25-068530
Chunk: 5

Company: Gain Therapeutics, Inc.
Filing Date: 2025-07-17
Form: 8-K
Item: Item 7.01
Chunk 5
---
Item 7.01. Regulation FD Disclosure.

On July 15, 2025, the Company issued a press release regarding the
launch of the Offering (the “ Launch Press Release”). On July 16, 2025, the Company issued a press release announcing
that it had priced the Offering (the “Pricing Press Release”). Copies of the Launch Press Release and the Pricing Press
Release are furnished hereto as Exhibit 99.1 and Exhibit 99.2, respectively.